Most Affordable Depression Treatments in Chicago
Innovative Ketamine is proud to offer new, reduced pricing to make treatment more affordable. IV Ketamine for mood disorders is now just $350. This is the lowest price in the Chicagoland area. If another clinic tells you they accept insurance for IV infusions, please beware. Insurance providers (including BCBS and Medicare) consider Ketamine infusions for mood disorders to be an off-label use of the drug. As such, only the initial consultation is eligible for insurance. Insurance companies are beginning to look at this closely, so if a clinic bills your insurance, you may be left with an unexpected bill. We lowered our prices to make IV Ketamine as affordable as possible for Innovative Ketamine patients.
Why Innovative Ketamine?
Innovative Ketamine has a 75 percent success rate for the treatment of depression. If you or a loved one are suffering, schedule a consultation today. It’s time to get back to the life you love.
Dr. Khare was among the first physicians in Chicago to offer ketamine infusions. He is a board certified emergency physician who spent over a decade at Northwestern Medicine before opening his own group of medical practices. Innovative Ketamine has been successfully treating patients with IV ketamine since 2018. We have an experienced team of providers who understand and specialize in ketamine treatment. We also have therapists on-site to guide patients through their treatment journey.
Ketamine for Depression
Your first treatment will be a discussion of your past medical history, a discussion of ketamine, going over treatment plan and goals, reviewing the risks and benefits of the procedure and answering all your questions. If you have insurance, we do accept insurance for this visit.
Patients typically receive a series of 6 infusions over the course of approximately two weeks for mood disorders. Each infusion typically lasts about 45-55 minutes. Most clinical trials have consistently shown a 70-75% success rate with this approach, however, based on our clinical experience, we are seeing an 80% success rate. The treatment does require booster infusions as time passes to keep the effect going and to keep patients symptom-free. These boosters are the same duration and are usually done once a month.
Ketamine for Pain
Generally, two types of patients with chronic pain may benefit from this medication: patients with chronic pain that have not had much success with other pain medications or treatments, and/or patients with chronic pain who plan to undergo surgery.
Several conditions, including cancer, CRPS, fibromyalgia, neuropathic pain, phantom pain, postherpetic neuralgia, sickle cell disease, and spinal injury, may result in chronic pain. Ketamine has been used to manage pain in all of these conditions. Multiple professional organizations, including the American Society of Regional Anesthesia and Pain Medicine (ASRA), the American Academy of Pain Medicine (AAPM), and the American Society of Anesthesiologists (ASA), have agreed that the collective evidence has shown support for ketamine’s role in managing pain for these conditions.
The pain protocol differs significantly than the protocol for depression or other mood disorders. For the pain protocol, the patient is given a 3 hour infusion of Ketamine. Also, the dosage is significantly higher than for the mood disorder protocol. Due to this increase in dosage, patients tend to get some more side-effects (nausea, dizziness, longer disassociation) compared to the depression protocol. This being said, our patients tend to do very well with our pain protocols.
Now Offering Spravato (Esketamine)
Spravato (aka Esketamine) is a new, FDA approved medication, which is an isomer of Ketamine (aka racemic ketamine).
Spravato is an FDA approved medication (it may be covered by insurance). However, we must use the medication exactly as the FDA approved it, thus there are restrictions on how it must be administered.